Gavi | New “Blockbuster” TB Vaccines Could Save Seven Million Lives by 2050

14 September 2026

Gavi news release

New TB vaccines, which are expected to become available from 2029, could help save up to an estimated 7.3 million lives between 2030 and 2050, unlocking up to US$ 135 billion in economic benefits across low- and middle-income countries, according to new analysis on their potential impact. These benefits highlight the potential for new TB vaccines to become one of the most impactful new immunisation tools in decades, representing a breakthrough technology in fighting the world’s deadliest infectious disease.

Nevertheless, in its Early Market Shaping Roadmap for Novel TB Vaccines, Gavi, the Vaccine Alliance (Gavi) warns that action is required now to prepare governments and vaccine manufacturers for the vaccines’ arrival. According to the Roadmap, demand for the vaccines among low-income countries and middle-income countries could reach, on average, 86 million vaccination courses per year, with greater demand in the early years as high-burden countries seek to expand protection across multiple age groups in high-risk areas.

Read the full news release here.

Source: Gavi